Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Visual Acuity Outcomes and Anti-Vascular Endothelial Growth Factor Therapy Intensity in Neovascular Age-Related Macular Degeneration Patients: A Real-World Analysis of 49‚ÄČ485 Eyes.

Ciulla TA, Hussain RM, Pollack JS, Williams DF.

Ophthalmol Retina. 2019 May 25. pii: S2468-6530(19)30280-5. doi: 10.1016/j.oret.2019.05.017. [Epub ahead of print]

PMID:
31324588
2.

Small gauge vitrectomy: operative techniques.

Pollack JS, Sabherwal N.

Curr Opin Ophthalmol. 2019 May;30(3):159-164. doi: 10.1097/ICU.0000000000000568. Review.

PMID:
30883444
3.

Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema: Extrapolation of Data to Clinical Practice.

Heier JS, Bressler NM, Avery RL, Bakri SJ, Boyer DS, Brown DM, Dugel PU, Freund KB, Glassman AR, Kim JE, Martin DF, Pollack JS, Regillo CD, Rosenfeld PJ, Schachat AP, Wells JA 3rd; American Society of Retina Specialists Anti-VEGF for Diabetic Macular Edema Comparative Effectiveness Panel.

JAMA Ophthalmol. 2016 Jan;134(1):95-9. doi: 10.1001/jamaophthalmol.2015.4110.

PMID:
26512939
4.

Comparison of topical anesthetics for intravitreal injections : a randomized clinical trial.

Davis MJ, Pollack JS, Shott S.

Retina. 2012 Apr;32(4):701-5. doi: 10.1097/IAE.0b013e31822f27ca.

PMID:
22282296
5.

Endophthalmitis in microincision vitrectomy: outcomes of gas-filled eyes.

Chiang A, Kaiser RS, Avery RL, Dugel PU, Eliott D, Shah SP, Heier J, Duker J, Hu AY, Schwartz SD, Scott IU, Pollack JS, Faia LJ, Williams GA.

Retina. 2011 Sep;31(8):1513-7. doi: 10.1097/IAE.0b013e3182209290.

PMID:
21878799
6.

Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study.

Nguyen QD, Shah SM, Khwaja AA, Channa R, Hatef E, Do DV, Boyer D, Heier JS, Abraham P, Thach AB, Lit ES, Foster BS, Kruger E, Dugel P, Chang T, Das A, Ciulla TA, Pollack JS, Lim JI, Eliott D, Campochiaro PA; READ-2 Study Group.

Ophthalmology. 2010 Nov;117(11):2146-51. doi: 10.1016/j.ophtha.2010.08.016. Epub 2010 Sep 19. Erratum in: Ophthalmology. 2011 Jun;118(6):1016. Eliot, Dean [corrected to Eliott, Dean].

PMID:
20855114
7.

Sustained postoperative face-down positioning is unnecessary for successful macular hole surgery.

Mittra RA, Kim JE, Han DP, Pollack JS.

Br J Ophthalmol. 2009 May;93(5):664-6. doi: 10.1136/bjo.2008.148544. Epub 2009 Jan 23.

PMID:
19168466
8.

Short-term outcomes of 23-gauge pars plana vitrectomy.

Gupta OP, Ho AC, Kaiser PK, Regillo CD, Chen S, Dyer DS, Dugel PU, Gupta S, Pollack JS.

Am J Ophthalmol. 2008 Aug;146(2):193-197. doi: 10.1016/j.ajo.2008.04.010. Epub 2008 Jun 10.

PMID:
18547538
9.

ISIS-DME: a prospective, randomized, dose-escalation intravitreal steroid injection study for refractory diabetic macular edema.

Kim JE, Pollack JS, Miller DG, Mittra RA, Spaide RF; Isis Study Group.

Retina. 2008 May;28(5):735-40. doi: 10.1097/IAE.0b013e318163194c.

PMID:
18463518
10.

Vitrectomy for a symptomatic lamellar macular hole.

Garretson BR, Pollack JS, Ruby AJ, Drenser KA, Williams GA, Sarrafizadeh R.

Ophthalmology. 2008 May;115(5):884-886.e1. Epub 2007 Dec 11.

PMID:
18067968
11.
12.

The artificial silicon retina microchip for the treatment of vision loss from retinitis pigmentosa.

Chow AY, Chow VY, Packo KH, Pollack JS, Peyman GA, Schuchard R.

Arch Ophthalmol. 2004 Apr;122(4):460-9.

PMID:
15078662
13.

Is coxsackievirus the cause of unilateral acute idiopathic maculopathy?

Beck AP, Jampol LM, Glaser DA, Pollack JS.

Arch Ophthalmol. 2004 Jan;122(1):121-3. No abstract available. Erratum in: Arch Ophthalmol. 2005 Jan;123(1):63. Glasser, David A [corrected to Glaser, David A].

PMID:
14718310
14.

Improve adolescents' access to emergency contraception.

Pollack JS, Daley AM.

Nurse Pract. 2003 Aug;28(8):11-23; quiz 24-5. Review. No abstract available.

PMID:
12902937
15.

Clinical characteristics of central serous chorioretinopathy in women.

Perkins SL, Kim JE, Pollack JS, Merrill PT.

Ophthalmology. 2002 Feb;109(2):262-6.

PMID:
11825806
16.

SdeK, a histidine kinase required for Myxococcus xanthus development.

Pollack JS, Singer M.

J Bacteriol. 2001 Jun;183(12):3589-96.

17.

Fatal outcome after embolotherapy for hepatic arteriovenous malformations of the liver in two patients with hereditary hemorrhagic telangiectasia.

Whiting JH Jr, Korzenik JR, Miller FJ Jr, Pollack JS, White RI Jr.

J Vasc Interv Radiol. 2000 Jul-Aug;11(7):855-8. No abstract available.

PMID:
10928521
18.

The use of topical aqueous suppressants in the prevention of postoperative intraocular pressure elevation after pars plana vitrectomy with long-acting gas tamponade.

Mittra RA, Pollack JS, Dev S, Han DP, Mieler WF, Pulido JS, Connor TB.

Ophthalmology. 2000 Mar;107(3):588-92.

PMID:
10711900
19.

The asgE locus is required for cell-cell signalling during Myxococcus xanthus development.

Garza AG, Harris BZ, Pollack JS, Singer M.

Mol Microbiol. 2000 Feb;35(4):812-24.

20.

Progressive changes in the fluorescein and indocyanine green angiogram in acute idiopathic maculopathy.

Akduman LS, Feiner MS, Pollack JS, Kaplan HJ.

Ocul Immunol Inflamm. 1999 Jun;7(2):97-102.

PMID:
10420205
21.
22.

Tissue effects of subclinical diode laser treatment of the retina.

Pollack JS, Kim JE, Pulido JS, Burke JM.

Arch Ophthalmol. 1998 Dec;116(12):1633-9.

PMID:
9869794
23.

Green- and red-fluorescent nanospheres for the detection of cell surface receptors by flow cytometry.

Bhalgat MK, Haugland RP, Pollack JS, Swan S, Haugland RP.

J Immunol Methods. 1998 Oct 1;219(1-2):57-68.

PMID:
9831388
24.

SdeK is required for early fruiting body development in Myxococcus xanthus.

Garza AG, Pollack JS, Harris BZ, Lee A, Keseler IM, Licking EF, Singer M.

J Bacteriol. 1998 Sep;180(17):4628-37.

25.

Submacular surgery for subfoveal choroidal neovascular membranes in patients with presumed ocular histoplasmosis.

Berger AS, Conway M, Del Priore LV, Walker RS, Pollack JS, Kaplan HJ.

Arch Ophthalmol. 1997 Aug;115(8):991-6.

PMID:
9258220
26.

Golf-related ocular injuries.

Pollack JS, Mieler WF, Mittra RA.

Curr Opin Ophthalmol. 1997 Jun;8(3):15-8. Review.

PMID:
10168889
27.

Ocular complications in Ehlers-Danlos syndrome type IV.

Pollack JS, Custer PL, Hart WM, Smith ME, Fitzpatrick MM.

Arch Ophthalmol. 1997 Mar;115(3):416-9. No abstract available.

PMID:
9076218
28.

Bull's eye maculopathy in arcuate pigment epithelial dystrophy.

Mittra RA, Pollack JS, Mieler WF.

Retina. 1997;17(6):551-3. No abstract available.

PMID:
9428020
29.

Postoperative abnormalities of the choriocapillaris in exudative age-related macular degeneration.

Pollack JS, Del Priore LV, Smith ME, Feiner MA, Kaplan HJ.

Br J Ophthalmol. 1996 Apr;80(4):314-8.

30.

Prevalence of retinal hemorrhages in infants after extracorporeal membrane oxygenation.

Pollack JS, Tychsen L.

Am J Ophthalmol. 1996 Mar;121(3):297-303.

PMID:
8597273

Supplemental Content

Loading ...
Support Center